Advanced search
Start date
Betweenand


Characterization of the signaling pathways triggered by the PrPc-p66 and PrPc-laminin interactions and their relevance in the processes of programmed cell death and memory consolidation

Full text
Author(s):
Adriana Regina de Oliveira Freitas
Total Authors: 1
Document type: Doctoral Thesis
Press: São Paulo.
Institution: Universidade de São Paulo (USP). Conjunto das Químicas (IQ e FCF) (CQ/DBDCQ)
Defense date:
Examining board members:
Ricardo Renzo Brentani; Jose Eduardo Krieger; Joao Gustavo Pessini Amarante Mendes; Ana Maria Moura da Silva; Glaucia Mendes Souza
Advisor: Ricardo Renzo Brentani
Abstract

PrPc is an extremely conserved 35 KDa glycoprotein which seems to be essential during the transmission and pathogenesis of several neurodegenerative diseases like bovine spongiform encephalopathy or Creutzfeldt-Jacob disease (PRUSINER, 1991). Although the physiological function of this protein remains unclear, it is well established that prion diseases require PrPc expression and are often characterized by deposition of an abnormal PrPc isoform, named PrPsc (GABIZON et. al., 1997). Interested in the normal fuction of PrPc, our group has been dedicated to study the interations that PrPc could entertain with other molecules. We have identified and characterized two interactions in which PrPc is involved: with a 66 KDa ligand protein, recently identified as the STI1 protein (ZANATA et. al., 2002) and with laminin (GRANER et. al., 2000). In this work, we have investigated the signaling pathways triggered by these interactions, as well as their relevance in programmed cell death and memory formation mechanisms. We show in this work that PrPc-p66 interaction transduces neuroprotective signals through a cAMP/PKA-dependent pathway in the neuroblastic layer of rodents\' retina. Moreover, we demonstrated that PrPc-laminin interaction has an important role for short-term memory formation through the activation of cAMP-PKA-MAPK pathways and for long-term memory with the activation of the cAMP/PKA pathway only. (AU)